Study extends understanding of blood cell mutations as cardiovascular risk factor

A newly-released study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor. Details were reported by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Spanish National Center for Cardiovascular Research, the research entity which facilitated the study, published in the journal, Nature Cardiovascular Research.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,United States ,Madrid ,Spanish ,American ,Hematovascular Pathophysiology ,Derekm Klenin ,Richard Gorlin ,Valentin Fuster ,Javier Fuster ,Nuria Matesanz ,Investigaciones Cardiovasculares ,Alexander Bick ,Salud Carlos ,Investigaciones Cardiovasculares Carlos ,Pradeep Natarajan ,Md Heart Research Foundation Professor ,Leducq Foundation ,Barcelona City Council ,Nature Cardiovascular Research On ,American Association For The Advancement Of Science ,Cardiovascular Research ,Journal Of The American College Cardiology ,Sinai School Of Medicine ,Cardiovascular Research Foundation ,Spanish National Center ,Nature Cardiovascular Research ,Icahn School Of Medicine At Mount Sinai ,Department Of Veterans Affairs ,Mount Sinai Health System ,Us National Institutes Of Health ,Stanford University ,General Director ,Mount Sinai ,American Association ,Assistant Professor ,Stanford Medicine ,Massachusetts General Hospital ,Assitant Professor ,Genetic Medicine ,Vanderbilt University Medical Center ,Mount Sinai Heart ,Mount Sinai Hospital ,American College ,Instituto De Salud Carlos ,Heart Research Foundation Professor ,Icahn School ,Transcatheter Cardiovascular Therapeutics ,Career Achievement Award ,Sinai Hospital ,Sinai School ,Gold Medal ,